Difference between revisions of "DallasWorkshop"

From NCBO Wiki
Jump to navigation Jump to search
m
m
Line 14: Line 14:
  
 
----
 
----
'''Overview'''
+
'''''Overview'''''
  
 
The goals of clinical and translational research are to achieve a better understanding of the pathogenesis of human disease in order to develop effective diagnostic, therapeutic and prevention strategies. Biomedical informatics can play an important role is supporting this research by facilitating the management, integration, analysis and exchange of data derived from and related to the research problems being studied. A key aspect of this support is to bring clarity, rigor and formalism to the representation of  
 
The goals of clinical and translational research are to achieve a better understanding of the pathogenesis of human disease in order to develop effective diagnostic, therapeutic and prevention strategies. Biomedical informatics can play an important role is supporting this research by facilitating the management, integration, analysis and exchange of data derived from and related to the research problems being studied. A key aspect of this support is to bring clarity, rigor and formalism to the representation of  

Revision as of 13:38, 24 June 2008

Signs, Symptoms and Findings: First Steps Toward an Ontology of Clinical Phenotypes


Workshop organized by: Richard Scheuermann, University of Texas Southwestern Medical Center, Dallas

Sponsored by: National Center for Biomedical Ontology (NCBO) and University of Texas Southwestern Medical Center, Dallas Clinical and Translational Science Award (CTSA) Program

Date: September 3-4, 2008

Venue: Dallas/Fort Worth Airport Marriott [1]. Details with regard to discounted room rate will be sent to confirmed participants in due course.

Signs, Symptoms and Findings: First Steps Toward an Ontology of Clinical Phenotypes is funded by the United States National Institutes of Health (NIH) through the NIH Roadmap for Medical Research, Grant 1 U54 HG004028. Information on the National Centers for Biomedical Computing can be found at: [2].


Overview

The goals of clinical and translational research are to achieve a better understanding of the pathogenesis of human disease in order to develop effective diagnostic, therapeutic and prevention strategies. Biomedical informatics can play an important role is supporting this research by facilitating the management, integration, analysis and exchange of data derived from and related to the research problems being studied. A key aspect of this support is to bring clarity, rigor and formalism to the representation of

1. disease initiation, progression, pathogenesis, signs, symptoms, assessments, clinical and laboratory findings, disease diagnosis, treatment, treatment response and outcome, and
2. the interrelations between these distinct entities both in patient management and in clinical research,

thus allowing the data to be more readily retrievable and shareable, and more able to serve in the support of algorithmic reasoning.


Goals

The tentative goals of the workshop will be to:

  • Utilize consistent ontological design and development principles to describe disease signs and symptoms, clinical and laboratory findings, and their interrelations.
  • Delineate the roles that signs, symptoms and findings play in both clinical patient management and in clinical research.
  • Develop a clear understanding and representation of the distinction between clinical and pre-clinical manifestations of signs, symptoms and findings.
  • Take first steps towards harmonizing the ontological representation of disease signs and symptoms and clinical and laboratory findings with existing and emerging standards in knowledge representation from the health informatics and bioinformatics communities
  • Explore incorporation of the results of this work into the CTSA Human Studies Metadata Repository framework

Provisional list of participants

This is a working meeting and participation is restricted. Those wishing to communicate their interest in attending should contact Dr Richard Scheuermann as soon as possible. The following is a provisional list of attendees:

  • Robert Arp (National Center for Biomedical Ontology / University at Buffalo)
  • Elmer V. Bernstam (University of Texas at Houston)
  • Jon Blumenfeld (Weill Cornell Medical Center)
  • Anita Burgun (Université de Rennes)
  • Helen Chen (Phillips)
  • Chris Chute (Mayo Clinic)
  • Sheri de Coronado (National Cancer Institute / NIH)
  • Amar K. Das (Stanford Center for Biomedical Informatics Research)
  • Louis J. Goldberg (University at Buffalo)
  • Jeff Grethe (BIRN / University of California at San Diego)
  • Herb Hagler (University of Texas Southwestern Medical Center)
  • William Hogan (University of Pittsburgh Medical Center)
  • Warren Kibbe (Northwestern University)
  • Suzanne Lewis (Lawrence Berkeley National Laboratory)
  • Mark Musen (Stanford Center for Biomedical Informatics Research)
  • Meredith Nahm (Duke Translational Medicine Institute)
  • Daniel Rubin (Stanford Center for Biomedical Informatics Research)
  • Neil Sarkar (Marine Biological Laboratory, Woods Hole)
  • Richard Scheuermann (University of Texas Southwestern Medical Center)
  • Barry Smith (National Center for Biomedical Ontology / University at Buffalo)
  • Kent Spackman (International Health Terminology Standards Development Organization)
  • Ashley Xia (NIAID / NIH)
  • Samson Tu (Stanford Center for Biomedical Informatics Research)

In addition to NCBO and the University of Texas Southwestern Medical Center, it is our goal to have the following communities represented: CTSA, HL7, CDISC, SNOMED, and OBO, as well as the NIH.


Tentative Agenda

Day 1

8:30am Registration and Continental Breakfast

• Session 1 - Health care and clinical research perspective o Presentations by local clinicians and clinical investigators o Presentations of selected CTSA use cases

• Session 2 - Brief overview of ontology formalisms

• Session 3 - Brief presentations of existing and emerging standards regarding the use of terminologies related to signs, symptoms and findings

• Session 4 - Proposals for ontology-based clarification and unification of ‘sign’, ‘symptom’, ‘finding’ and related terms with the goal of achieving improved understanding of what they are and how they relate to each other


Day 2

8:30am Continental Breakfast

• Session 5 - Working session to utilize consistent ontological design and development principles to describe disease signs and symptoms, clinical and laboratory finding, and their interrelations

• Session 6 - Discussion of strategies to achieve convergence between the ontological representation of disease signs and symptoms and clinical and laboratory findings with the existing and emerging standards in knowledge representation from the health informatics and bioinformatics communities

4:00pm Close